RSDFX
Price
$41.21
Change
-$0.06 (-0.15%)
Updated
Sep 5 closing price
Net Assets
2.17B
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

RSDFX vs VVIAX

Header iconRSDFX vs VVIAX Comparison
Open Charts RSDFX vs VVIAXBanner chart's image
Columbia Dividend Opportunity Inst2
Price$41.21
Change-$0.06 (-0.15%)
VolumeN/A
Net Assets2.17B
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
RSDFX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RSDFX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSDFX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. RSDFX (2.17B). RSDFX pays higher dividends than VVIAX: RSDFX (2.72) vs VVIAX (2.10). RSDFX was incepted earlier than VVIAX: RSDFX (17 years) vs VVIAX (25 years). RSDFX (0.79) is less costly to investors than VVIAX (0.05). RSDFX is a more actively managed with annual turnover of: 36.00 vs. VVIAX (9.00). RSDFX has a lower initial minimum investment than VVIAX: RSDFX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. RSDFX (6.72). VVIAX return over 5 years is better than : 70.16 vs. RSDFX (46.14).
RSDFXVVIAXRSDFX / VVIAX
Total Expense Ratio0.790.051,580%
Annual Report Gross Expense Ratio0.790.051,580%
Fund Existence17 years25 years-
Gain YTD10.3557.850132%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.17B203B1%
Annual Yield % from dividends2.722.10129%
Returns for 1 year6.727.7487%
Returns for 3 years26.5036.6172%
Returns for 5 years46.1470.1666%
Returns for 10 years48.52131.6137%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGS11.340.60
+5.59%
Aligos Therapeutics Inc
AEG7.52-0.03
-0.40%
Aegon Ltd
LFST5.37-0.10
-1.83%
LifeStance Health Group
TATT33.82-0.81
-2.34%
TAT Technologies Ltd
CNET1.51-0.06
-3.81%
ZW Data Action Technologies Inc